[Drug-induced visual disturbance].
Imaizumi
Masamoto
M
Department of Ophthalmology, Shinbeppu Hospital.
Ikebe
Toru
T
Ikewaki
Junko
J
Nakatsuka
Kazuo
K
D000638:Amiodarone / Q000009:adverse effects*; D018927:Anti-Asthmatic Agents / Q000009:adverse effects*; D000962:Antimalarials / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects; D000998:Antiviral Agents / Q000009:adverse effects*; D002738:Chloroquine / Q000009:adverse effects; D002746:Chlorpromazine / Q000009:adverse effects; D018492:Dopamine Antagonists / Q000009:adverse effects; D004977:Ethambutol / Q000009:adverse effects; D005128:Eye Diseases / Q000139:chemically induced*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007372:Interferons / Q000009:adverse effects*; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects; D010879:Piperazines / Q000009:adverse effects; D011687:Purines / Q000009:adverse effects; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000009:adverse effects
D018927:Anti-Asthmatic Agents; D000962:Antimalarials; D000995:Antitubercular Agents; D000998:Antiviral Agents; D018492:Dopamine Antagonists; D005938:Glucocorticoids; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D002738:Chloroquine; D004977:Ethambutol; D007372:Interferons; D000068677:Sildenafil Citrate; D000638:Amiodarone; D002746:Chlorpromazine